Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...

Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

Sales in the Pharmaceuticals Division were up 8% in the first quarter to CHF 11.9 billion, owing to strong growth in demand for key drugs like Phesgo (breast cancer), Vabysmo (severe eye diseases ...

Cardiovascular drug Entresto sales witnessed a solid year-over-year surge in the fourth quarter of 2024, driven by robust demand-led growth, with increased penetration in the United States and ...

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).